James Pettitt - Concepedia

Author

James Pettitt

National Institute of Allergy and Infectious Diseases

Also Known As

Danielle Peart, J Pettitt, James D. Pettitt, James Pettitt, Martine Peeters, Paulty, Michael H., Pettitt, James, Vincent J Munster

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

National Institute of Allergy and Infectious Diseases National Institutes of Health United States Army Medical Research Institute of Infectious Diseases Mapp Biopharmaceutical (United States)University of Minnesota

About

James Pettitt is an author at National Institute of Allergy and Infectious Diseases specializing in medicine, virology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	2K
2	Immunology	8	8	967
3	Epidemiology	6	6	655
4	Microbiology	2	2	104
5	Allergy	1	1	27

James Pettitt

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp Xiangguo Qiu, Gary Wong, Jonathan Audet, Nature Emerging Infectious DiseasesViral PathogenesisEmergent VirusPathologyVirology	2014	976
Molecular Evidence of Sexual Transmission of Ebola Virus Suzanne Mate, Jeffrey R. Kugelman, Tolbert Nyenswah, New England Journal of Medicine Virus EpidemiologyMolecular EvidenceMedicinePathogenesisImmunology	2015	427
Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques Gene G. Olinger, James Pettitt, Do Hyoung Kim, Proceedings of the National Academy of Sciences	2012	369
Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant Larry Zeitlin, James Pettitt, Corinne Scully, Proceedings of the National Academy of Sciences ImmunodeficienciesImmunologyImmunodominanceSimilar PotencyImmunotherapeutics	2011	228
Therapeutic Intervention of Ebola Virus Infection in Rhesus Macaques with the MB-003 Monoclonal Antibody Cocktail James Pettitt, Larry Zeitlin, Do H. Kim, Science Translational Medicine	2013	220
Monitoring of Ebola Virus Makona Evolution through Establishment of Advanced Genomic Capability in Liberia Jeffrey R. Kugelman, Michael R. Wiley, Suzanne Mate, Emerging infectious diseases Virus EpidemiologyViral DiagnosticsImmunologyDisease OutbreakWestern Africa	2015	84
3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012 Reed F. Johnson, Lauren Keith, Xianchun Tang, Virology Lung InflammationRhesus MonkeysHumoral ResponseViral PathogenesisImmunology	2016	77
Ebola Virus Neutralizing Antibodies Detectable in Survivors of theYambuku, Zaire Outbreak 40 Years after Infection Anne W. Rimoin, Kai Lü, Matthew S. Bramble, The Journal of Infectious Diseases VaccinationVp40 ReactivityVirus EpidemiologyNeutralization CapacityVaccine Target	2017	65
Lateral Flow Immunoassays for Ebola Virus Disease Detection in Liberia Jill C. Phan, James Pettitt, Josiah George, The Journal of Infectious Diseases	2016	48
Use of the Filovirus Animal Non-Clinical Group (FANG) Ebola virus immuno-assay requires fewer study participants to power a study than the Alpha Diagnostic International assay James Logue, Kaylie Tuznik, Dean Follmann, Journal of Virological Methods Virus EpidemiologyViral DiagnosticsImmunologyFewer Study ParticipantsStandardized Assays	2018	38

Page 1